Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - COMMON STOCK REPURCHASED
Common Stock Repurchased HALO - Halozyme Therapeutics, Inc.
-250 M
LAST VALUE
-11.80%
2 YEAR CAGR
-4.56%
5 YEAR CAGR
0.00%
10 YEAR CAGR